| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Negotiation > Negotiations Between Artist and Gallery-Contracts Must Be Clear, Flattery Gets Ya Nowhere Pt. 1 |
|
Advice You - Negotiations Between Artist and Gallery-Contracts Must Be Clear, Flattery Gets Ya Nowhere Pt. 1
Part One: New galleries and their quest for a team of artists and According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product vice versa must be done artfully. Artists and galleries need to think thin ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s through before making requests or shipping out art. You have to put lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. yourself in an artist's place. Here I am not knowing you or perhaps anything here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe about the location. You contact me, like my art and want it. Cool, I appr d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ciate the contact and compliment. Yet, if you are asking me to consign my ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc work you become a voice over the phone or internet without credentials. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi had my work in a gallery in San Francisco on Union Square years ago. There w nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically as no contract and being a fledgling artist I did not ask for one. I was simp and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y thrilled to be in a gallery in Union Square. There was a wonderful opening ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hat I attended with all the other artists who had become part of the gallery. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Wonderful food and wine were served and important people came, everything an dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rtists desires from a gallery. Living somewhat close to that gallery made cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin it convenient to pop in on occasion. I went a few times to make contact with tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the gallery owner and see about future shows. Time went by and my contacts be t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ame less and more by phone. I later learned that the gallery owner had been ' ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust renting out' the paintings to banks and corporate offices. That is not an unu y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ual thing to do but it is unusual that the artist not be informed of it and re . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ceive a cut. I had no idea where my paintings were from one week to the ne elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t. Continued on part two ---------------------------- tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Printed Promotional Pens Advertise Your Corporate Business Creating Your Niche & Brand - Part 2
|